在庫拠点

New Jersey, USA
Czech Republic, EU
Mumbai, India

* 在庫状況によります

Documentation

MSDSをダウンロード

サンプルCOAをダウンロード

内容: HPLC、MASS/LC-MS、1H NMR、FT-IR、含量、構造解析レポート（SER）、および製品に応じた追加分析データ。

Abiraterone Acetate Diastereomer

● Under Development

カタログ番号:	VL830014
CAS番号:	N/A
分子式:	C26H33NO2
分子量:	391.56 g/mol

ご用件は何ですか?

RFQリストに追加

に関する追加情報 Abiraterone Acetate Diastereomer

親薬物

Abiraterone

IUPAC名

(3S, 8R, 9S, 10R, 13S, 14S)-10, 13-dimethyl-17-(pyridin-3-yl)-2, 3, 4, 7, 8, 9, 10, 11, 12, 13, 14, 15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate

薬局方同義語

N/A

Other Synonyms

17-(Pyridin-3-yl)androsta-5,16-dien-3B-yl acetate

SMILES

CC(O[C@H]1CC[C@]2(C)[C@@]3([H])CC[C@]4(C)C(C5=CC=CN=C5)=CC[C@@]4([H])[C@]3([H])CC=C2C1)=O

InChI

InChI=1S/C26H33NO2/c1-17(28)29-20-10-12-25(2)19(15-20)6-7-21-23-9-8-22(18-5-4-14-27-16-18)26(23,3)13-11-24(21)25/h4-6,8,14,16,20-21,23-24H,7,9-13,15H2,1-3H3/t20-,21-,23-,24-,25-,26+/m0/s1

説明

Abiraterone Acetate Diastereomer is an enantiomer of abiraterone acetate prescribed for patients with castration-resistant prostate cancer. Abiraterone -acetate is a prodrug that is converted in vivo to abiraterone having an androgen biosynthesis inhibitory property.

References

Mach, Samuel, et al. â€œEpoxidation Is the Preferred Pathway of First-Stage Metabolism of Abiraterone Acetate in Brown Bullhead (Ameiurus Nebulosus).â€Â Environmental Science and Pollution Research, vol. 26, no. 34, Oct. 2019, pp. 34896â€“904, https://doi.org/10.1007/s11356-019-06568-y.